• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后心血管疾病的危险因素。

Risk factors for cardiovascular disease after renal transplantation.

作者信息

Kasiske B L

机构信息

Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415.

出版信息

Miner Electrolyte Metab. 1993;19(3):186-95.

PMID:8232106
Abstract

The incidence of cardiovascular disease is high after renal transplantation. Risk factors include pretransplant cardiovascular disease, diabetes, male sex, serum cholesterol, hypertension, cigarette smoking, and allograft dysfunction. Prevention of cardiovascular disease can probably best be approached by modifying multiple risk factors. Thus, efforts should be made to identify and treat patients with severe coronary artery disease before transplantation. After transplantation, hypertension and hyperlipidemia should be treated, and efforts should be made to help patients abstain from smoking. Chronic immunosuppression protocols should attempt to balance the need to prevent allograft rejection with the known adverse effects of immunosuppressive agents on cardiovascular disease. Altogether, an aggressive, coordinated program to modify multiple risk factors is probably the best approach to the prevention of cardiovascular disease after renal transplantation.

摘要

肾移植后心血管疾病的发病率很高。危险因素包括移植前心血管疾病、糖尿病、男性、血清胆固醇、高血压、吸烟和同种异体移植功能障碍。预防心血管疾病最好的方法可能是改变多个危险因素。因此,应努力在移植前识别并治疗患有严重冠状动脉疾病的患者。移植后,应治疗高血压和高脂血症,并努力帮助患者戒烟。慢性免疫抑制方案应试图在预防同种异体移植排斥反应的需求与免疫抑制剂对心血管疾病的已知不良影响之间取得平衡。总之,一个积极的、协调的改变多个危险因素的方案可能是预防肾移植后心血管疾病的最佳方法。

相似文献

1
Risk factors for cardiovascular disease after renal transplantation.肾移植后心血管疾病的危险因素。
Miner Electrolyte Metab. 1993;19(3):186-95.
2
[Cardiovascular disease after renal transplantation].[肾移植后的心血管疾病]
G Ital Nefrol. 2004 Jan-Feb;21 Suppl 26:S53-66.
3
[Cardiovascular risk and renal transplantation].[心血管风险与肾移植]
G Ital Nefrol. 2004 Mar-Apr;21(2):144-55.
4
Cardiovascular disease after renal transplantation.肾移植后的心血管疾病
Semin Nephrol. 2000 Mar;20(2):176-87.
5
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.心脏移植后心脏移植血管病变:危险因素与管理
J Heart Lung Transplant. 2004 May;23(5 Suppl):S187-93. doi: 10.1016/j.healun.2004.03.009.
6
Dyslipidemia and its management after renal transplantation.肾移植后的血脂异常及其管理
J Nephrol. 2001 Nov-Dec;14 Suppl 4:S81-8.
7
Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients.高血压与肾移植受者的高脂血症、冠心病和慢性移植失败有关。
Clin Nephrol. 1999 May;51(5):290-5.
8
Cardiovascular risk estimates and risk factors in renal transplant recipients.肾移植受者的心血管风险评估及风险因素
Transplant Proc. 2005 May;37(4):1868-70. doi: 10.1016/j.transproceed.2005.04.009.
9
Cardiovascular risk factors in renal transplantation--current controversies.肾移植中的心血管危险因素——当前争议
Nephrol Dial Transplant. 2006 Jul;21 Suppl 3:iii3-8. doi: 10.1093/ndt/gfl298.
10
[Hypertension after kidney transplantation].[肾移植术后高血压]
Lijec Vjesn. 2006 Nov-Dec;128(11-12):373-8.

引用本文的文献

1
Calcineurin inhibitors and post-transplant hyperlipidaemias.钙调神经磷酸酶抑制剂与移植后高脂血症
Drug Saf. 2001;24(10):755-66. doi: 10.2165/00002018-200124100-00004.
2
A practical guide to the management of hypertension in renal transplant recipients.肾移植受者高血压管理实用指南
Drugs. 1999 Dec;58(6):1011-27. doi: 10.2165/00003495-199958060-00005.
3
Fluvastatin (Lescol) treatment of hyperlipidaemia in patients with renal transplants.氟伐他汀(来适可)治疗肾移植患者的高脂血症。
Int Urol Nephrol. 1997;29(1):95-106. doi: 10.1007/BF02551424.
4
Pancreas transplantation.胰腺移植
Int J Pancreatol. 1995 Feb;17(1):1-13. doi: 10.1007/BF02788353.